Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
5.65
-0.03 (-0.53%)
At close: Oct 13, 2025, 4:00 PM EDT
5.61
-0.04 (-0.71%)
After-hours: Oct 13, 2025, 6:24 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $954.98 million as of October 13, 2025. Its market cap has increased by 140.80% in one year.
Market Cap
954.98M
Enterprise Value
957.76M
1-Year Change
140.80%
Ranking
Category
Stock Price
$5.65
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $954.98M, a decrease of -41.32%. That is a compound annual growth rate of -16.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 960.05M | 157.68% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |